Skip to content
Tissue
Fetal kidney
Disease
Normal fetal kidney (retroviral packaging cell line; non-tumorigenic)
Metastatic site
Not applicable (non-tumorigenic packaging cell line)
Synonyms
ProPakA.6, PPA.6, PP-A.6

Documents

ProPak-A.6

Cell line · Product number 305599

US$0.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

ProPak-A.6 (PPA.6) is a human fetal kidney-derived packaging cell line generated for the production of replication-incompetent retroviral vectors. ProPak-A.6 stably expresses adenovirus-5 E1A sequences (for transcriptional transactivation) together with gag-, pol-, and env-related proteins derived from murine leukemia virus (MLV), enabling efficient packaging of recombinant retroviral genomes into non-infectious MLV-based viral particles. The GMO-S1 classification reflects the stable integration of these viral transgenes.

ProPak-A.6 is applicable as a packaging cell line for generating high-titer recombinant MLV-based retroviral vectors for gene transfer into target cells. It is used in gene therapy vector production, stable transduction of dividing cell populations, and studies requiring efficient retroviral delivery of transgenes. The adenovirus E1A component enhances promoter-driven expression, improving viral production efficiency. Users should follow applicable biosafety regulations for BSL-2 retroviral vector work.

Tissue
Fetal kidney
Disease
Normal fetal kidney (retroviral packaging cell line; non-tumorigenic)
Metastatic site
Not applicable (non-tumorigenic packaging cell line)
Applications
Retroviral vector production; gene therapy vector manufacturing; stable transduction of dividing cells; MLV-based retroviral gene delivery; adenovirus-assisted retroviral packaging; gene transfer research
Synonyms
  • ProPakA.6
  • PPA.6
  • PP-A.6

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
GMO status
GMO-S1
GMO status details
GMO-S1: This human kidney-derived cell line (ProPaka.6) contains plasmid constructs encoding adenovirus-5 sequences together with gag-, pol-, and env-related proteins that form non-infectious murine leukemia virus particles. The inserts are stably integrated. This classification applies only within Germany and may differ elsewhere.
Biosafety level
2

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 24 to 36 hours

04Identifiers

Citation
ProPak-A.6 (Cytion catalog number 305599)
NCBI TaxID
9606
Cellosaurus
CVCL_8968

05Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
Accutase
Subculturing
Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
Split ratio
1 to 5
Seeding density
1 to 3 × 10⁴ cells/cm²
Fluid renewal
Every 1 to 2 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

06Quality control and cryopreservation

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
Fetus